Related Articles
Inflammatory myofibroblastic tumor of the urinary bladder with FN1‑ALK gene fusion: A case report
ALK‑positive locally advanced lung cancer in a patient who achieved long‑term complete response with crizotinib: A case report
Successful treatment of EGFR-mutated non-small cell lung cancer with reduced-dose gefitinib: A case report
Long‑term complete response in a patient with postoperative recurrent ALK‑rearranged lung adenocarcinoma treated with crizotinib: A case report
Response to erlotinib in a patient with lung adenocarcinoma harbouring the EML4-ALK translocation: A case report